Medifocus, Inc., a medical technology company, develops and commercialises minimally invasive focused heat systems for the treatment of cancerous and benign tumours and enlarged prostates in Canada and the United States. The company owns technology platforms, including the Endo-thermotherapy Platform, a catheter-based focused heat technology platform that utilises natural body openings to deliver microwave thermotherapy to the diseased sites, and the Adaptive Phased Array (APA) Microwave Focusing Platform, which directs focused microwave energy at the tumour centre to induce shrinkage or eradication of tumours without undue harm to surrounding tissue. It also offers the Prolieve Thermodilatation System, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. The company was incorporated in 2005 and is based in Toronto, Canada.